Drug recall · July 29, 2015
Famotodine Tablets recall
Why: CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 Count Drums, Over the Counter. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0374-09.
- Lots / codes
Lot #: LN11320, Expiry: 7/31/2015; Lot #: LN11341, Expiry: 8/31/2015.
- Quantity
- 539 Drums
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- U.S. Nationwide including Puerto Rico.
- Initiated
- April 22, 2015 · Voluntary: Firm initiated
- Classified
- July 17, 2015
- Reported
- July 29, 2015
- Ended
- May 9, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.